Tetralogy of fallot prevention: Difference between revisions
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; '''Associate Editors-In-Chief:''' [[Priyamvada Singh| Priyamvada Singh, M.B.B.S.]] [mailto:psingh@perfuse.org], [[User:KeriShafer|Keri Shafer, M.D.]] [mailto:kshafer@bidmc.harvard.edu]; '''Assistant Editor-In-Chief:''' [[Kristin Feeney|Kristin Feeney, B.S.]] [mailto:kfeeney@perfuse.org] | {{CMG}}; '''Associate Editors-In-Chief:''' [[Priyamvada Singh| Priyamvada Singh, M.B.B.S.]] [mailto:psingh@perfuse.org], [[User:KeriShafer|Keri Shafer, M.D.]] [mailto:kshafer@bidmc.harvard.edu]; '''Assistant Editor-In-Chief:''' [[Kristin Feeney|Kristin Feeney, B.S.]] [mailto:kfeeney@perfuse.org] | ||
==Overview== | ==Overview== | ||
Factors that reduce [[systemic vascular resistance]] ([[SVR]]) may exacerbate shunting which in turn exacerbates cyanosis and should be avoided if at all possible in the patient with Tetralogy of Fallot. | |||
==Prevention== | ==Prevention== | ||
No known prevention exists for | No known prevention exists for Tetralogy of Fallot. | ||
==Prevention of Cyanosis== | ==Prevention of Cyanosis== | ||
| Line 18: | Line 20: | ||
:*[[Dehydration]] | :*[[Dehydration]] | ||
:*Closure of the [[patent ductus arteriosus]] | :*Closure of the [[patent ductus arteriosus]] | ||
==Prevention of Infective Endocarditis== | |||
*Antibiotic prophylaxis should be administered. | |||
==References== | ==References== | ||
Revision as of 18:39, 16 April 2012
|
Tetralogy of fallot Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
|
|
Tetralogy of fallot prevention On the Web |
|
American Roentgen Ray Society Images of Tetralogy of fallot prevention |
|
Risk calculators and risk factors for Tetralogy of fallot prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Priyamvada Singh, M.B.B.S. [2], Keri Shafer, M.D. [3]; Assistant Editor-In-Chief: Kristin Feeney, B.S. [4]
Overview
Factors that reduce systemic vascular resistance (SVR) may exacerbate shunting which in turn exacerbates cyanosis and should be avoided if at all possible in the patient with Tetralogy of Fallot.
Prevention
No known prevention exists for Tetralogy of Fallot.
Prevention of Cyanosis
The following factors may reduce systemic vascular resistance (SVR) and exacerbate shunting which in turn exacerbate cyanosis and should be avoided if at all possible:
- Acidosis
- Bathing in hot water
- Fever
- Stress
- Infection
- Posture (upright, not squatting)
- Exercise
- Beta-adrenergic agonists
- Dehydration
- Closure of the patent ductus arteriosus
Prevention of Infective Endocarditis
- Antibiotic prophylaxis should be administered.
References
External links
- Information for adults with ToF from the Adult Congenital Heart Association
de:Fallot-Tetralogie it:Tetralogia di Fallot nl:Tetralogie van Fallot nn:Fallots tetrade uk:Тетрада Фалло